During the past decade, Cancer & Blood Disease Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 6 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer & Blood Disease Center" #1 sponsor was "Celgene" with 6 trials, followed by "Pfizer" with 4 trials sponsored, "Point Therapeutics" with 2 trials sponsored, "Amgen" with 1 trials sponsored and "BioCryst Pharmaceuticals" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer & Blood Disease Center" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator and "Medivation, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Cancer & Blood Disease Center" are "Carcinoma, Non-Small-Cell Lung" (3 trials), "Myelodysplastic Syndromes" (3 trials), "Multiple Myeloma" (2 trials), "Relapsed Multiple Myeloma" (2 trials) and "BRCA 1 Gene Mutation" (1 trials). Many other conditions were trialed in "Cancer & Blood Disease Center" in a lesser frequency.

Most popular intervention types in "Cancer & Blood Disease Center" are "Drug" (16 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (3 trials), "lenalidomide" (3 trials), "Lenalidomide" (2 trials), "Axitinib" (1 trials) and "Binimetinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cancer & Blood Disease Center" are 16 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Cancer & Blood Disease Center". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Cancer & Blood Disease Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer & Blood Disease Center, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".